North East and North Cumbria
ICS Formulary
ICS Formulary
4 Central nervous system
04-01-02 Benzodiazepines
| Lorazepam |
|
Formulary
|
 MHRA Drug Safety Update (October 2007): Lorazepam: reduction of recommended maximum daily dose |
|
Links
- MHRA Drug Safety Alert (Feb 2015): Drugs and driving: blood concentration limits set for certain drugs
- MHRA Drug Safety Update (Apr 2022): Pregabalin (Lyrica): findings of safety study on risks during pregnancy
- MHRA Drug Safety Update (Feb 2021): Pregabalin (Lyrica): reports of severe respiratory depression
- MHRA Drug Safety Update (October 2007): Lorazepam: reduction of recommended maximum daily dose
- MHRA Drug Safety Update March 2020: Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression
NENC Palliative and End of Life Care Symptom Control Guidelines- NICE CG113: Generalised anxiety disorder and panic disorder in adults: management
- NICE NG10: Violence and aggression: short-term management in mental health, health and community settings
- NICE NG62: Cerebral palsy in under 25s: assessment and management
- TEWV - Medicines Optimisation – Interactive Guide
- TEWV Guidelines
- TEWV Safe Transfer of Prescribing Guidance
- TEWV: Anxiety medication pathway for adults